Mukul Agrawal picks 1.14% stake in smallcap stock in Q1FY26
Ace investor Mukul Mahavir Agrawal acquired a 1.14% stake in Yatharth Hospital & Trauma Care Services in the June 2025 quarter, purchasing 11 lakh shares worth around Rs 68.1 crore. Following the update, the stock rose 3% in Thursday’s trade on th...

Agrawal acquired 11,00,000 shares, valued at approximately Rs 68.1 crore based on the current market price of Rs 618.2.
In today’s trade, Yatharth Hospital shares surged 3% on BSE. The stock has gained 40% over the past six months.
Also Read: 9 undervalued mid-cap stocks with upside potential of up to 23%
In the same quarter, he also increased his stake in small-cap multibagger Prakash Industries by 0.3%, taking his total holding to 1.72% or 30,27,554 shares.
Meanwhile, earlier, Agrawal also trimmed his holdings in two small-cap stocks — Sula Vineyards and Raghav Productivity Enhancers — during the quarter ended June 30, 2025. His stake in Sula Vineyards fell by 41 basis points (bps) over the March quarter, bringing his current holding to 1.78%. In Raghav Productivity, the stake was reduced by 51 bps to 1.04%, according to BSE data.
In contrast, Raghav Productivity had rallied 56% in the last 12 months, outperforming the Nifty’s 2% gain during the same period. The recent trimming appears to be profit-booking, especially as the stock has declined over 5% in 2025, while the Nifty has gained more than 5%.
Mukul Agrawal Portfolio
Agrawal, known for identifying multibaggers, publicly holds 61 stocks with a combined net worth of over Rs 6,870 crore as of the June quarter. His top holdings include Neuland Laboratories, BSE, Radico Khaitan, Nuvama Wealth, Deepak Fertilisers, Intellect Design, and PTC Industries.
In the June quarter, Agrawal also added SME stock Monolithisch India to his portfolio, purchasing 5 lakh shares or a 2.30% stake. Additionally, he acquired a 1.27% stake in Jammu & Kashmir Bank.
Also Read: SBI, Federal Bank among 11 banks that saw NPA improvement in Q4
(Disclaimer: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Download ET Markets APP